Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119107592 | 11910759 | 2 | F | 20160902 | 20160112 | 20160914 | EXP | US-PFIZER INC-2015477964 | PFIZER | 59.00 | YR | F | Y | 0.00000 | 20160914 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119107592 | 11910759 | 1 | PS | IBRANCE | PALBOCICLIB | 1 | 125 MG, CYCLIC (21 DAYS THEN 7 DAYS) | U | 207103 | 125 | MG | CAPSULE | |||||||
119107592 | 11910759 | 2 | SS | FEMARA | LETROZOLE | 1 | UNK | U | 0 | ||||||||||
119107592 | 11910759 | 3 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK DF, AS NEEDED (5/300, 1 Q 4-6 HOURS P.R.N) | 0 | |||||||||||
119107592 | 11910759 | 4 | C | XGEVA | DENOSUMAB | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119107592 | 11910759 | 1 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119107592 | 11910759 | DS |
119107592 | 11910759 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119107592 | 11910759 | Back pain | |
119107592 | 11910759 | Bone marrow failure | |
119107592 | 11910759 | Musculoskeletal chest pain | |
119107592 | 11910759 | Pain in extremity | |
119107592 | 11910759 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |